About Check-Cap
Check-Cap is a company based in Haifa (Israel) founded in 2005.. Check-Cap has raised $9.88 million across 15 funding rounds from investors including GE Healthcare, General Electric and Fosun Pharmaceutical. Check-Cap offers products and services including C-Scan System. Check-Cap operates in a competitive market with competitors including IGM Biosciences, New Element Medicine, Zymedi, Brenus Pharma and Promis Diagnostics, among others.
- Headquarter Haifa, Israel
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Check-Cap Ltd.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-25.15 M-43.15as on Dec 31, 2024
-
EBITDA
$-9.3 M47.3as on Dec 31, 2024
-
Total Equity Funding
$9.88 M (USD)
in 15 rounds
-
Latest Funding Round
$9.63 M (USD), Post-IPO
Jul 23, 2020
-
Investors
GE Healthcare
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Check-Cap
Check-Cap is a publicly listed company on the NASDAQ with ticker symbol CHEK in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Check-Cap
Check-Cap offers a comprehensive portfolio of products and services, including C-Scan System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Preparation-free test for detecting precancerous polyps in cancer screening
Unlock access to complete
Funding Insights of Check-Cap
Check-Cap has successfully raised a total of $9.88M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $9.63 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Post-IPO — $9.6M
-
First Round
First Round
(24 Mar 2011)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Post-IPO - Check-Cap | Valuation |
investors |
|
| May, 2020 | Amount | Post-IPO - Check-Cap | Valuation |
investors |
|
| Apr, 2020 | Amount | Post-IPO - Check-Cap | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Check-Cap
Check-Cap has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include GE Healthcare, General Electric and Fosun Pharmaceutical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pontifax Venture Capital is focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Investments are directed toward Israeli technology startups by Docor.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Check-Cap
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Check-Cap
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Check-Cap Comparisons
Competitors of Check-Cap
Check-Cap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IGM Biosciences, New Element Medicine, Zymedi, Brenus Pharma and Promis Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibodies for cancer and infectious disease treatments are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for cancer and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for multiple diseases are developed using Aminoacyl-tRNA Synthetase technology.
|
|
| domain | founded_year | HQ Location |
Immunotherapy for cancer treatment is developed by Brenus Pharma.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostics for colorectal cancer screening are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Check-Cap
Frequently Asked Questions about Check-Cap
When was Check-Cap founded?
Check-Cap was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Where is Check-Cap located?
Check-Cap is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Is Check-Cap a funded company?
Check-Cap is a funded company, having raised a total of $9.88M across 15 funding rounds to date. The company's 1st funding round was a Post-IPO of $4.5M, raised on Mar 24, 2011.
What does Check-Cap do?
Check-Cap was founded in 2005 in Haifa, Israel, and operates in the medical technology sector. Non-invasive imaging capsules are developed for colorectal cancer screening, eliminating the need for bowel preparation or invasive procedures. Polyps are detected with high sensitivity through structural examinations. The technology has been validated in animal studies, supporting early cancer detection efforts.
Who are the top competitors of Check-Cap?
Check-Cap's top competitors include IGM Biosciences, Zymedi and Brenus Pharma.
What products or services does Check-Cap offer?
Check-Cap offers C-Scan System.
Is Check-Cap publicly traded?
Yes, Check-Cap is publicly traded on NASDAQ under the ticker symbol CHEK.
Who are Check-Cap's investors?
Check-Cap has 8 investors. Key investors include GE Healthcare, General Electric, Fosun Pharmaceutical, Ministry of Economy and industry, and Pontifax Venture Capital.
What is Check-Cap's ticker symbol?
The ticker symbol of Check-Cap is CHEK on NASDAQ.